Indrayani Biotech share news, announcements and annual reports
BSE: 526445Agricultural Food & other ProductsSmall Cap
Indrayani Biotech Ltd. · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed May 1994
Last close ₹8.05up ₹0.24 (3.07%)
Share price at the BSE close on 30 Oct 2026. Previous close ₹7.81.
30 Oct: open ₹7.81, high ₹8.13, low ₹7.47
52-week range of traded prices to 30 Oct 2026
₹6.10Low, 19 Mar 2026₹16.47High, 6 Nov 2025
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹37 Cr3,322nd largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- Owners' profit not stated
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 0.50
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 1.9%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 1.26
- Volume, BSEVolume. Shares traded on the last trading day. Volume in the glossary
- 21,374
Indrayani Biotech board meetings
163 filed, newest first. Page 1 of 4.
Sep 2026
30 Sep · Board meeting
Meeting on 7 Oct 2026: quarterly results
Aug 2026
12 Aug · Board meeting
Meeting on 17 Aug 2026: audited results
Apr 2026
9 Apr · Board meeting
6 Apr · Board meeting
Meeting on 9 Apr 2026: scheme of arrangement
Mar 2026
Feb 2026
23 Feb · Board meeting
Meeting on 26 Feb 2026: quarterly results
Dec 2025
5 Dec · Board meeting
Meeting on 11 Dec 2025: quarterly results
Nov 2025
13 Nov · Board meeting
Meeting on 14 Nov 2025: quarterly results
Aug 2025
30 Aug · Board meeting
26 Aug · Board meeting
Meeting on 30 Aug 2025: annual general meeting11 Aug · Board meeting
Meeting on 14 Aug 2025: quarterly results
Jun 2025
12 Jun · Board meeting
9 Jun · Board meeting
Meeting on 12 Jun 2025: audited results
May 2025
Apr 2025
3 Apr · Board meeting
Mar 2025
27 Mar · Board meeting
Meeting on 3 Apr 2025: rights issue of equity shares
Feb 2025
27 Feb · Board meeting
Meeting on 27 Feb 2025: quarterly results10 Feb · Board meeting
Meeting on 14 Feb 2025: quarterly results
Nov 2024
11 Nov · Board meeting
Meeting on 14 Nov 2024: rights issue of equity shares and quarterly results
Aug 2024
14 Aug · Board meeting
8 Aug · Board meeting
Meeting on 14 Aug 2024
Jul 2024
24 Jul · Board meeting
Meeting on 27 Jul 2024: annual general meeting and increase in authorised capital
May 2024
23 May · Board meeting
Meeting on 30 May 2024: audited results
Feb 2024
5 Feb · Board meeting
Meeting on 10 Feb 2024: quarterly results
Jan 2024
8 Jan · Board meeting
Meeting on 10 Jan 2024: increase in authorised capital
Nov 2023